Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis
Authors
Keywords
Melanoma, Toll-like receptors, Prognosis
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume 305, Issue 1, Pages 59-67
Publisher
Springer Nature
Online
2012-11-20
DOI
10.1007/s00403-012-1300-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
- (2011) Arcadi Cipponi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptors and skin
- (2011) A.T. Ermertcan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Activation of Toll-like Receptors 1, 2, 4, 5, and 7 on Human Melanocytes Modulate Pigmentation
- (2010) Sun Hee Jin et al. Annals of Dermatology
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells
- (2010) Deepak Mittal et al. EMBO JOURNAL
- The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
- (2010) Rosaria Cammarota et al. Journal of Translational Medicine
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Toll‐like receptors and adaptor molecules in liver disease: Update
- (2008) Ekihiro Seki et al. HEPATOLOGY
- Immunotherapy for Advanced Melanoma
- (2008) Lei Fang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Imiquimod, a Toll-Like Receptor 7 Agonist, Inhibits Melanogenesis and Proliferation of Human Melanocytes
- (2008) Hee Young Kang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors
- (2008) Y. Goto et al. MOLECULAR CANCER THERAPEUTICS
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
- TLR3 and TLR4 expression in healthy and diseased human endometrium
- (2008) Svenja Allhorn et al. Reproductive Biology and Endocrinology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started